Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Gray

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Plos One|October 8, 2013
The distribution and 'in vivo' phase variation status of haemoglobin receptors in invasive meningococcal serogroup B disease: genotypic and phenotypic analysisJay Lucidarme, Jamie Findlow, Hannah Chan, et al.
Clinical and Vaccine Immunology : CVI|June 28, 2013
Genetic distribution of noncapsular meningococcal group B vaccine antigens in Neisseria lactamicaJay Lucidarme, Stefanie Gilchrist, Lynne S Newbold, et al.
Clinical and Vaccine Immunology : CVI|April 9, 2010
Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccineJay Lucidarme, Maurizio Comanducci, Jamie Findlow, et al.
Vaccine|March 21, 2012
Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccinesShamez N Ladhani, Jessica S Flood, Mary E Ramsay, et al.
The Lancet. Public Health|December 19, 2017
Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort studyMirjam J Knol, Susan J M Hahné, Jay Lucidarme, et al.
The Journal of Infectious Diseases|March 3, 2007
Three cases of invasive meningococcal disease caused by a capsule null locus strain circulating among healthy carriers in Burkina FasoHelen Findlow, Ulrich Vogel, Judith E Mueller, et al.
Journal of Clinical Microbiology|September 18, 2009
Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and WalesJay Lucidarme, Maurizio Comanducci, Jamie Findlow, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2003
Interlaboratory comparison of agar dilution and Etest methods for determining the MICs of antibiotics used in management of Neisseria meningitidis infectionsJulio A Vázquez, Luisa Arreaza, Colin Block, et al.
Journal of Clinical Microbiology|May 30, 2008
Opa protein repertoires of disease-causing and carried meningococciMartin J Callaghan, Caroline Buckee, Noel D McCarthy, et al.
Microbiology (Reading, England)|February 12, 2011
Influence of the combination and phase variation status of the haemoglobin receptors HmbR and HpuAB on meningococcal virulenceIsfahan Tauseef, Odile B Harrison, Karl G Wooldridge, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Plos One|October 8, 2013
The distribution and 'in vivo' phase variation status of haemoglobin receptors in invasive meningococcal serogroup B disease: genotypic and phenotypic analysisJay Lucidarme, Jamie Findlow, Hannah Chan, et al.
Clinical and Vaccine Immunology : CVI|June 28, 2013
Genetic distribution of noncapsular meningococcal group B vaccine antigens in Neisseria lactamicaJay Lucidarme, Stefanie Gilchrist, Lynne S Newbold, et al.
Clinical and Vaccine Immunology : CVI|April 9, 2010
Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccineJay Lucidarme, Maurizio Comanducci, Jamie Findlow, et al.
Vaccine|March 21, 2012
Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccinesShamez N Ladhani, Jessica S Flood, Mary E Ramsay, et al.
The Lancet. Public Health|December 19, 2017
Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort studyMirjam J Knol, Susan J M Hahné, Jay Lucidarme, et al.
The Journal of Infectious Diseases|March 3, 2007
Three cases of invasive meningococcal disease caused by a capsule null locus strain circulating among healthy carriers in Burkina FasoHelen Findlow, Ulrich Vogel, Judith E Mueller, et al.
Journal of Clinical Microbiology|September 18, 2009
Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and WalesJay Lucidarme, Maurizio Comanducci, Jamie Findlow, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2003
Interlaboratory comparison of agar dilution and Etest methods for determining the MICs of antibiotics used in management of Neisseria meningitidis infectionsJulio A Vázquez, Luisa Arreaza, Colin Block, et al.
Journal of Clinical Microbiology|May 30, 2008
Opa protein repertoires of disease-causing and carried meningococciMartin J Callaghan, Caroline Buckee, Noel D McCarthy, et al.
Microbiology (Reading, England)|February 12, 2011
Influence of the combination and phase variation status of the haemoglobin receptors HmbR and HpuAB on meningococcal virulenceIsfahan Tauseef, Odile B Harrison, Karl G Wooldridge, et al.
Pageof 4